The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: A voxel-based morphometric study

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 1, 2006, Pages 60-66

  Pennanen, Corina ^a,b   Testa, Cristina ^d,e   Boccardi, Marina ^d   Laakso, Mikko P ^a,b   Hallikainen, Merja ^a   Helkala, Eeva Liisa ^b   Hänninen, Tuomo ^a   Kivipelto, Miia ^a   Könönen, Mervi ^a   Nissinen, Aulikki ^c   Tervo, Susanna ^a,b   Vanhanen, Matti ^a   Vanninen, Ritva ^a   Frisoni, Giovani B ^d   Soininen, Hilkka ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

Author keywords

Alzheimer's disease; Amygdala; Apolipoprotein E; Entorhinal cortex; Hippocampus; Magnetic resonance imaging; Mild cognitive impairment; Thalamus; Voxel based morphometry

Indexed keywords

APOLIPOPROTEIN E;

AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; CONTROLLED STUDY; DNA POLYMORPHISM; ENTORHINAL CORTEX; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUBICULUM; THALAMUS NUCLEUS;

AGED; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS; APOLIPOPROTEINS E; ATROPHY; BRAIN; COGNITION DISORDERS; COHORT STUDIES; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC;

EID: 33745211474     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093263     Document Type: Article

References (60)

1. Saunders AM, Trowers MK, Shimkets RA, Blakemore S, Crowther DJ, Mansfield TA, Wallace DM, Strittmatter WJ, Roses AD: The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochim Biophys Acta 2000;1502:85-94.
2. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, PericakVance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
3. Alberts MS: Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci USA 1996;93:13547-13551.
4. Engelborghs S, Dermaut B, Goeman J, Saerens J, Marien P, Pickut BA, Van den Broeck M, Serneels S, Cruts M, Van Broeckhoven C, De Deyn PP: Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 2003;74:1148-1151.
5. Lehtovirta M, Laakso MP, Frisoni GB, Soininen H: How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging 2000;21:293-300.
6. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
7. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D: Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58:643-647.
8. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH: Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Part 2. Arch Neurol 2003;60:1394-1399.
9. Tervo S, Kivipelto M, Hanninen T, Vanhanen M, Hallikainen M, Mannermaa A, Soininen H: Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004;17:196-203.
10. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
11. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142.
12. Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM: Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003;2:79-88.
13. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C: Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002;13:1939-1943.
14. Chételat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, Desgranges B, Baron J-C: Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005;27:934-946.
15. Pennanen C, Testa C, Laakso MP, Perrone MG, Hallikainen M, Helkala EL, Hänninen T, Kivipelto M, Könönen M, Nissinen A, Tuomainen S, Vanhanen M, Vanninen R, Frisoni GB, Soininen H: A voxel-based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005;76:11-14.
16. Karas GB, Scheltens P, Rombouts SARB, Visser PJ, van Schijndel RA, Fox NC, Barkhof F: Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004;23:708-716.
17. Bell-McGinty S, Lopez OL, Meltzer CC, Scanlon JM, Whyte EM, DeKosky ST, Becker JT: Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005;62:1393-1397.
18. Hänninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H: Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002;106:148-154.
19. Kivipelto M, Helkala E-L, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001;56:1683-1689.
20. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala E-L, Vainio P, Vanninen R, Partanen K, Soininen H: Hippocampus and entorhinal cortex in mild cognitive impairment. Neurobiol Aging 2004;25:303-310.
21. Smith GE, Petersen RC, Parisi JE, Ivnik RJ, Kokmen E, Tangalos EG, Waring S: Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol Cogn 1996;3:141-147.
22. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T: Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
23. Rorden C, Brett M: Stereotaxic display of brain lesions. Behav Neurol 2001;112:191-200.
24. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS: A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001;14:21-36.
25. Evans AC, Kamber M, Collins DL, Macdonald D: An MRI-based probabilistic atlas of neuroanatomy; in Shorvon S, Fish D, Andermann F, et al (eds): Magnetic Resonance Scanning and Epilepsy. New York, Plenum Press, 1994, pp 263-274.
26. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F: In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001;14:298-309.
27. Ashburner J, Friston KJ: Why voxel-based morphometry should be used. Neuroimage 2001;14:1238-1243.
28. Geroldi C, Pihlajamäki M, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB: ApoE ε4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 1999;53:1825-1832.
29. Geroldi C, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB: Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry 2000;68:93-96.
30. Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJ Sr, Soininen H: Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E ε4 allele. J Neurol Neurosurg Psychiatry 1998;65:322-327.
31. Lehtovirta M, Soininen H, Laakso MP, Partanen K, Helisalmi S, Mannermaa A, Ryynanen R, Kuikka J, Hartikainen P, Riekkinen PJ Sr: SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E ε4 allele. J Neurol Neurosurg Psychiatry 1996;60:644-649.
32. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
33. Braak H, Braak E, Bohl J: Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33:403-408.
34. Chen R, Herskovits EH: Network analysis of mild cognitive impairment. Neuroimage 2005;2006;29:1252-1259.
35. Braak H, Braak E: Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 1991;81:261-268.
36. Jernigan TL, Salmon DP, Butters N, Hesselink JR: Cerebral structure on MRI. II. Specific changes in Alzheimer's and Huntingtons diseases. Biol Psychiatry 1991;29:68-81.
37. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, McKeith IG, Williams D, Ballard C, Barkhof F: A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003;18:895-907.
38. Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J: Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci USA 2001;98:3334-3339.
39. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
40. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996;334:752-758.
41. Desgranges B, Baron J-C, de la Sayette V, Petit-Taboue M-C, Landeau B, Eustache F: The neural substrates of memory systems impairment in Alzheimer's disease - A PET study of resting brain glucose utilization. Brain 1998;121:611-631.
42. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C: Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374-1377.
43. Nestor PJ, Fryer TD, Smielewski P, Hodges JR: Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 2003;54:343-351.
44. Nestor PJ, Scheltens P, Hodges JR: Advances in the early detection of Alzheimer's disease. Nat Med 2004;10(suppl):S34-41.
45. Cao Q, Jiang K, Liu Y, Zhang M, Xiao S, Zuo C, Huang H: The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment. Zhonghua Yi Xue Za Zhi 2002;82:1613-1616.
46. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP: Detection of gray matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry 2002;73:657-664.
47. Ohnishi T, Matsuda H, Tabira T, et al: Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 2001;22:1680-1685.
48. Rambouts SA, Barkhof F, Witter MP, Scheltens P: Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-233.
49. Soininen H, Partanen K, Pitkänen A, Hallikainen M, Hänninen T, Helisalmi S, Mannermaa A, Ryynänen M, Koivisto K, Riekkinen P Sr: Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele. Neurology 1995;45:391-392.
50. Tohgi H, Takahashi S, Kato E, Homma A, Niina R, Sasaki K, Yonezawa H, Sasaki M: Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ε4 allele. Neurosci Lett 1997;236:21-24.
51. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala E-L, Partanen K, Ryynänen M, Vainio P, Hartikainen P, Riekkinen PJ Sr: Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995;67:65-72.
52. Boccardi M, Sabattoli F, Testa C, Beltramello A, Soininen H, Frisoni GB: APOE modulation of Alzheimer's and frontotemporal dementia. Neurosci Lett 2004;356:167-170.
53. Boccardi M, Pennanen C, Laakso MP, Testa C, Geroldi C, Soininen H, Frisoni GB: Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease. Neurosci Lett 2002;335:139-143.
54. Cuénod CA, Denys A, Michot J-L, Jehenson P, Forette F, Kaplan D, Syrota A, Boller F: Amygdala atrophy in Alzheimer's disease: an in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-945.
55. Mann DMA: The neuropathology of the amygdala in ageing and in dementia; in Aggleton JP (ed): The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. New York, Wiley-Liss, 1992, pp 575-593.
56. Scott SA, DeKosky ST, Scheif SW: Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology 1991;41:351-356.
57. Vogt LJK, Human BT, Van Hoesen GW, Damasio AR: Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 1990;37:377-385.
58. Busatto GF, Garrido GEJ, Almeida OP, Castro CC, Camargo CHP, Cid CG, Buchpiguel CA, Furuie S, Bottino CM: A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003;24:221-231.
59. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS: Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002;17:29-46.
60. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF: Incidence and outcome in mild cognitive impairment in a population-based prospective cohort. Neurology 2002;26;59:1594-1599.